“Use of Ranibizumab for the Treatment of Subretinal Neovascularization in Pathologic Myopia: A Prospective Study”. Ukrainian Journal of Ophthalmology , no. 3, June 2026, pp. 10-14, https://doi.org/10.31288/oftalmolzh201631014.